[Linagliptin-induced liver toxicity]

Farm Hosp. 2017 Jul 1;41(4):561-562. doi: 10.7399/fh.2017.41.4.10763.

[Article in Spanish]

Authors

Emma Bartolomé-García¹, Sira Sanz-Márquez², Montserrat Pérez-Encinas³

Affiliations

¹ Servicio de Farmacia, Hospital Universitario Fundación Alcorcón, Madrid.. emmabgv@gmail.com.
² Servicio de Farmacia, Hospital Universitario Fundación Alcorcón, Madrid.. ssanz@fhalcorcon.es.
³ Servicio de Farmacia, Hospital Universitario Fundación Alcorcón, Madrid.. mperez@fhalcorcon.es.

PMID: 28683709
DOI: 10.7399/fh.2017.41.4.10763

No abstract available

Publication types

Case Reports

MeSH terms

Aged
Chemical and Drug Induced Liver Injury / etiology*
Diabetes Mellitus, Type 2 / complications
Diabetes Mellitus, Type 2 / drug therapy
Humans
Hypoglycemic Agents / adverse effects*
Hypoglycemic Agents / therapeutic use
Linagliptin / adverse effects*
Linagliptin / therapeutic use
Liver Function Tests
Male

Substances

Hypoglycemic Agents
Linagliptin